Deutsche Bank’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-290
Closed -$11.5K 3715
2023
Q3
$11.5K Hold
290
﹤0.01% 3550
2023
Q2
$11.9K Hold
290
﹤0.01% 3634
2023
Q1
$11.9K Hold
290
﹤0.01% 3767
2022
Q4
$11.9K Hold
290
﹤0.01% 3838
2022
Q3
$12K Buy
+290
New +$12.4K ﹤0.01% 3822
2019
Q3
Sell
-350,000
Closed -$13.9M 5321
2019
Q2
$13.9M Sell
350,000
-1,685
-0.5% -$66.3K 0.01% 1153
2019
Q1
$14.6M Buy
351,685
+1,685
+0.5% +$68.5K 0.01% 1145
2018
Q4
$12.8M Hold
350,000
0.01% 1152
2018
Q3
$17M Sell
350,000
-250,000
-42% -$11.8M 0.01% 1237
2018
Q2
$25.8M Hold
600,000
0.01% 1024
2018
Q1
$25.1M Buy
+600,000
New +$26.1M 0.01% 986
2015
Q1
Sell
-101,158
Closed -$5.46M 6058
2014
Q4
$5.46M Buy
101,158
+100,000
+8,636% +$5.46M ﹤0.01% 1887
2014
Q3
$61K Hold
1,158
﹤0.01% 4755
2014
Q2
$60K Hold
1,158
﹤0.01% 4841
2014
Q1
$54K Hold
1,158
﹤0.01% 4515
2013
Q4
$50K Sell
1,158
-1,158
-50% -$48.2K ﹤0.01% 4356
2013
Q3
$88K Sell
2,316
-198,800
-99% -$7.52M ﹤0.01% 4477
2013
Q2
$7.09M Buy
+201,116
New +$6.79M 0.01% 1419

Other funds holding XPH

Deutsche Bank's XPH Position: Q4 2023 in Review

Deutsche Bank sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2023, closing a stake of 290 shares — an estimated $11.5K sold.

Deutsche Bank first reported a position in XPH in Q2 2013 and held it in 18 quarters. The position peaked at $25.8M in Q2 2018. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2023.

  • Deutsche Bank reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
  • Deutsche Bank sold 290 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2023, an estimated $11.5K.
  • Deutsche Bank first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 18 quarters.
  • Deutsche Bank's State Street SPDR S&P Pharmaceuticals ETF position peaked at $25.8M in Q2 2018.
  • 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2023.

Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.